Unravel Biosciences
Pre-clinicalTransform the paradigm of drug development by clinically derisking new targets using existing drugs.
Founded
2019
Focus
Small Molecules
About
Transform the paradigm of drug development by clinically derisking new targets using existing drugs.
Funding History
2Total raised: $24.3M
Series A$20MDigitalis VenturesOct 15, 2023
Seed$4.3MDigitalis VenturesMar 15, 2022
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile